When it comes to staying hydrated, "just drink when you're thirsty" has been a rule of thumb for years. Yet a recent study by University of Arkansas researchers may prove that thirst alone is not a reliable indicator of proper ...
Apr 5, 2018
0
54
New research from City, University of London, University of Oxford and Yale University has shown that we see our own lives, and also those we care about, through 'rose-tinted glasses'.
Feb 2, 2018
0
79
Establishing the optimum "dose" of behavioral interventions to prevent and treat childhood obesity is critical for addressing the ongoing obesity epidemic and developing future interventions.
Dec 22, 2017
0
3
Immunotherapy agents known as checkpoint inhibitors have shown considerable promise in patients with hematologic cancers who relapse after a transplant with donor stem cells. Preliminary results from the first clinical trial ...
Dec 10, 2017
0
1
(HealthDay)—Key stakeholders and physicians discussed electronic health record (EHR) usability and optimization in the American Medical Association Running Your Practice Community.
Oct 19, 2017
0
0
Newly released recommendations for pediatric radiation safety will be discussed during the Society for Cardiovascular Angiography and Interventions (SCAI) 2017 Scientific Sessions in New Orleans. Theposition paper, "Radiation ...
May 9, 2017
0
0
A single dose of dextrose gel, rubbed inside a newborn's mouth an hour after birth, can lower their risk of developing neonatal hypoglycaemia, according to a randomized study published in PLOS Medicine by Jane Alsweiler from ...
Oct 25, 2016
0
4
A new study by King's College London, UCL and Birkbeck, University of London, casts doubt over claims that people are inherently over-optimistic or 'optimistically biased' about the future.
Aug 16, 2016
1
25
Aggressive neuroendocrine cancer is something of a dark horse—a rare, elusive and persevering force linked to discouraging long-term survival rates. Researchers at the 2016 Annual Meeting of the Society of Nuclear Medicine ...
Jun 13, 2016
0
0
An early group of patients who received a modified form of the poliovirus to treat recurrent glioblastoma brain tumors showed survival improvement over historical controls, according to researchers at the Preston Robert Tisch ...
Jun 7, 2016
0
0
